Our experiments showed the effectiveness of the drug in the treatment of RA, demonstrated by the decrease in signs of inflammation, both external and internal edema of the joints, as well as a decrease in lymphocytic infiltration of joint tissues, a decrease in the pannus, and decreases in the levels of TNF-α in the peripheral blood. This evidence concerns the gene TNF and rheumatoid arthritis.